In a recent study by Ward et al., anti-IgE CAR T cells were developed to attack cells with membrane bound IgE to reduce severe allergy and asthma, but soluble IgE in high concentrations rendered the CAR T cells less effective [216]. This evidence concerns the gene IGHE and allergic disease.